期刊文献+

左卡尼汀治疗慢性心力衰竭所致心肾综合征临床效果研究 被引量:7

Clinical efficacy of L-carnitine in treating cardiorenal syndrome results from chronic heart failure
下载PDF
导出
摘要 【目的】研究左卡尼汀对慢性心功能不全所致心肾综合征患者的心、肾功能的影响,为指导临床治疗提供理论依据。【方法】选择2007-2009年我院接诊的慢性心力衰竭合并肾功能损害患者63例,随机分为实验组31例和对照组32例,基础治疗相同,实验组联合应用左卡尼汀3 g/d,静脉滴注,疗程14 d,治疗后观察两组患者各项心肾功能指标变化情况,应用SPSS 17.0统计学软件进行数据分析。【结果】两组患者治疗后心肾功能评价指标明显改善。联合左卡尼汀治疗组血红蛋白、CysC及BNP浓度较对照组改善更为明显(P<0.05),LVEDD明显缩小(P<0.05),LVEF显著提高(P<0.05),两组血糖、血脂及血肌酐降低程度无统计学差异(P>0.05)。【结论】基础治疗联合左卡尼汀静脉滴注可进一步改善慢性心肾综合征患者的心肾功能指标。 【Objective】To investigate the effects of L-carnitine on cardiac and renal function in treating cardiorenal syndrome results from chronic heart failure,so as to provide additional theoretical basis for clinical treatment.【Methods】A total of 63 patients with chronic heart failure complicating kidney dysfunction were recruited from 2007 to 2009.These patients were randomly divided into vehicle treated group and L-carnitine treated group.All patients were treated with optimal pharmacotherapy according to guideline recommendations.Besides these,L-carnitine group were treated with intravenous drip of L-carnitine.The dosage was 3 g/d and the course of treatment was 14 days.Changes of cardiac and renal function of these two groups at the end were analyzed.SPSS 17.0 was used for data analysis.【Results】After treatment,there was marked amelioration of cardiac and renal function in both groups.Compared with the vehicle treated group,blood levels of hemoglobin increased in the L-carnitine group(P 0.05) especiallyin CysC and BNP both decreased(P 0.05).The left ventricular end diastolic diameter(LVEDD) decreased and left ventricular ejection fraction(LVEF) elevated(P 0.05).There was no significant difference in serum glucose,total cholesterol and creatinine in the two groups(P 0.05).【Conclusion】Intravenous drip of L-carnitine combined with basic pharmacotherapy treatment towards chronic cardiorenal syndrome could improve the cardiac and renal function than basic treatment.
出处 《武警医学院学报》 CAS 2011年第12期944-947,共4页 Acta Academiae Medicinae CPAPF
关键词 左卡尼汀 心肾综合征 心功能 肾功能 L-carnitine Cardiorenal syndrome Cardiac function Renal function
  • 相关文献

参考文献9

  • 1McAlister FA, Ezekowitz J, Tonelli M, et al.Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study[J]. Circulation, 2004, 109:1004-1009.
  • 2无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3691
  • 3Ronco C,Haapio M,House AA, et al. Cardiorenal syndrome [J]. J Am Coil Cardiol, 2008, 52(19):1527-1539.
  • 4Ronco C, House AA, Haapio M, et al. Cardiorenal and renocardiac syndromes: the need for a comprehensive classification and consensus[J]. Nat Clin Pract Nephrol, 2008, 4(6): 310-311.
  • 5Calvani M, Reda E, Arrigoni-Martelli E. Regulation by camitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions[J]. Basic Res Cardiol,2000,95(2):75-83.
  • 6Tarantini G, Scrutinio D, Bruzzi P, et al. Metabolic treatment with L-camitine in acute anterior ST segment elevation myocardial infarction. A randomized controlled trial[J]. Cardiology, 2006, 106(4):215-223.
  • 7Vescovo G, Ravara B, Gobbo V, et al. L-Carnitine:a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure[J]. Am J Physiol Cell Physiol, 2002, 283(3):C802-C810.
  • 8Csiky B, Nyul Z, T6th G, et al. L-carnitine supplementation and adipokines in patients with end-stage renal disease on regular hemodialysis[J]. Exp Clin Endocrinol Diabetes, 2010, 118(10):735-740.
  • 9Grubb A.Non-invasive estimation of glomerular filtration rate (GFR).The Lund model:Simultaneous use of cystatin C-and creatinine-based GFR-prediction equations,clinical data and anintenal quality check[J].Seand J Clin Lab Invest,2010, 70(2):65-70.

二级参考文献42

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
  • 2Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
  • 3Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
  • 4Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
  • 5Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
  • 6Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45.
  • 7Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2.
  • 8Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387.
  • 9Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J, 1999, 14(2) : 270-274.
  • 10Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next? Circulation, 2002, 105 (20):2328-2331.

共引文献3690

同被引文献49

引证文献7

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部